{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:34:02Z","timestamp":1791952442957,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194615"],"award-info":[{"award-number":["GNT1194615"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijid.2024.107283","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:34:17Z","timestamp":1731029657000},"page":"107283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Adverse reactions to trimethoprim\/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-7440","authenticated-orcid":false,"given":"Genevieve E.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5946-1987","authenticated-orcid":false,"given":"Joshua","family":"Bramwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4578-1566","authenticated-orcid":false,"given":"Eden","family":"Gadil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Woerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-7358","authenticated-orcid":false,"given":"Sonja","family":"Janson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-8837","authenticated-orcid":false,"given":"Bart J.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107283_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-023-00972-5","article-title":"Burkholderia pseudomallei and melioidosis","volume":"22","author":"Meumann","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2024.107283_bib0002","first-page":"3","article-title":"The 2024 revised Darwin Melioidosis Treatment Guideline. The Northern Territory Disease Control","volume":"30","author":"Currie","year":"2023","journal-title":"Bulletin"},{"key":"10.1016\/j.ijid.2024.107283_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12941-023-00620-z","article-title":"Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review","volume":"22","author":"Keragala","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijid.2024.107283_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijid.2019.01.019","article-title":"Oral eradication therapy for melioidosis: important but not without risks","volume":"80","author":"Sullivan","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107283_bib0005","doi-asserted-by":"crossref","first-page":"e3627","DOI":"10.1093\/cid\/ciaa1084","article-title":"A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial","volume":"73","author":"Anunnatsiri","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107283_bib0006","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S1473-3099(21)00022-0","article-title":"The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation","volume":"21","author":"Currie","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107283_bib0007","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ijid.2024.107283_bib0008","doi-asserted-by":"crossref","first-page":"ofad337","DOI":"10.1093\/ofid\/ofad337","article-title":"Longer-term mortality and kidney outcomes of participants in the combination antibiotics for methicillin-resistant Staphylococcus aureus (CAMERA2) trial: a post hoc analysis","volume":"10","author":"Legg","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2024.107283_bib0009","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3201\/eid2911.230951","article-title":"Clinical manifestations and genomic evaluation of melioidosis outbreak among children after sporting event, Australia","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2024.107283_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003586","article-title":"Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm","volume":"9","author":"Pitman","year":"2015","journal-title":"PLoS Neglect Trop Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:12:58Z","timestamp":1762366378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224003540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"alternative-id":["S1201971224003540"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107283","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse reactions to trimethoprim\/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107283"}}